Business Segments McKesson Corporation

Stocks

MCK

US58155Q1031

Pharmaceuticals

Market Closed - NYSE Other stock markets 01:30:02 16/07/2026 am IST			After hours 05:30:00 am
796.35 ^USD	-0.87%		926.65	+16.36%

15/07	Cheniere appoints former McKesson CFO to board	RE
14/07	Leerink Partners Adjusts Price Target on McKesson to $950 From $970, Maintains Outperform Rating	MT

Sales 2026 by Business Segment

Sales 2026 by Geography

Historical Breakdown of Revenue by Business Segments

Operating Income: Breakdown by Business Segment

Breakdown by Business Segment (USD)

Fiscal Period: March	2022	2023	2024	2025	2026
Pharmaceutical Product Distribution
North American Pharmaceutical	-	-	-	-	34TCr
CAPEX	-	-	-	-	-33Cr
D&A	-	-	-	-	13Cr
Operating Income	-	-	-	-	365.8Cr
Oncology & Multispecialty	-	-	-	-	4.84TCr
CAPEX	-	-	-	-	-7.8Cr
D&A	-	-	-	-	24Cr
Operating Income	-	-	-	-	114.9Cr
Other	-	-	-	-	104.3Cr
Total Assets	-	-	-	-	-
CAPEX	-	-	-	-	-1Cr
D&A	-	-	-	-	40L
Operating Income	-	-	-	-	59Cr
U.S. Pharmaceutical	21TCr	24TCr	28TCr	33TCr	-
Total Assets	3.83TCr	4.18TCr	4.68TCr	-	-
CAPEX	-14Cr	-15Cr	-19Cr	-24Cr	-
D&A	23Cr	21Cr	23Cr	23Cr	-
Operating Income	287.9Cr	320.6Cr	278.6Cr	400.2Cr	-
International	3.63TCr	2.06TCr	1.41TCr	1.47TCr	-
Total Assets	1.37TCr	622.6Cr	653.5Cr	-	-
CAPEX	-18Cr	-7.9Cr	-7.5Cr	-11Cr	-
D&A	20Cr	12Cr	12Cr	8.6Cr	-
Operating Income	-97Cr	14Cr	32Cr	-21Cr	-
European Pharmaceutical Solutions	-	-	-	-	-
Total Assets	-	-	-	-	-
CAPEX	-	-	-	-	-
D&A	-	-	-	-	-
Operating Income	-	-	-	-	-
U.S. Pharmaceutical and Specialty Solutions	-	-	-	-	-
Total Assets	-	-	-	-	-
CAPEX	-	-	-	-	-
D&A	-	-	-	-	-
Operating Income	-	-	-	-	-
Distribution Solutions	-	-	-	-	-
Total Assets	-	-	-	-	-
CAPEX	-	-	-	-	-
Gross Profit	-	-	-	-	-
D&A	-	-	-	-	-
Operating Income	-	-	-	-	-
Healthcare Equipment Distribution
Medical-Surgical Solutions	1.16TCr	1.11TCr	1.13TCr	1.14TCr	1.15TCr
Total Assets	583Cr	578Cr	623.3Cr	-	-
CAPEX	-7.4Cr	-12Cr	-16Cr	-16Cr	-9.4Cr
D&A	13Cr	8Cr	8.4Cr	9.3Cr	9.6Cr
Operating Income	96Cr	111.7Cr	95Cr	77Cr	94Cr
Healthcare Industry Software
Prescription Technology Solutions	386.4Cr	438.7Cr	476.9Cr	521.6Cr	580.5Cr
Total Assets	352.8Cr	416.8Cr	438.5Cr	-	-
CAPEX	-1Cr	-3.5Cr	-3.1Cr	-1.1Cr	-40L
D&A	8.2Cr	7.7Cr	8.4Cr	8.6Cr	8.2Cr
Operating Income	50Cr	57Cr	84Cr	88Cr	104.4Cr
Technology Solutions	-	-	-	-	-
Total Assets	-	-	-	-	-
CAPEX	-	-	-	-	-
Gross Profit	-	-	-	-	-
D&A	-	-	-	-	-
Operating Income	-	-	-	-	-
Corporate	-	-	-	1.1Cr	-
Total Assets	187.7Cr	435.3Cr	347.8Cr	-	-
CAPEX	-14Cr	-17Cr	-23Cr	-34Cr	-22Cr
D&A	12Cr	12Cr	12Cr	14Cr	17Cr
Operating Income	-	-	-	-	-93Cr